← Back
$INDV All transactions

Indivior Pharmaceuticals, Inc.

M

$ Value

Shares

23,975

Price

Filed

Mar 5

Insider

Name

Anderson Woodrow D

Title

Chief Accounting Officer

CIK

0002014440

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount. | Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. | Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026. | Shares used to satisfy tax withholding obligations associated with the vesting of restricted stock units on March 3, 2026. | This award is fully vested in accordance with its terms, effective March 3, 2026.

Filing Info

Accession No.

0002014440-26-000007

Form Type

4

Issuer CIK

0001625297

Anderson Woodrow D's History

Date Ticker Type Value
2026-03-03 INDV M
2026-03-03 INDV F $265K
2026-03-03 INDV M
2026-03-03 INDV F $86K
2026-03-03 INDV M
2026-03-03 INDV M
2026-02-10 INDV A $0
2026-02-09 INDV A $0

Other Insiders at INDV (90d)

Insider Bought Sold Last
Kingsley Stuart A $30K 2026-03-06
Ryan Barbara $1K 2026-03-13
NINIVAGGI DANIEL A 2026-01-26
Ciaffoni Joseph
Chief Executive Officer
2026-02-10
Burris Jeffrey W
Chief Legal Officer
2026-03-03
Stejbach Mark 2026-01-26
Thompson Juliet 2026-01-26
Barry Patrick A
Chief Commercial Officer
2026-02-10
Wheadon David E. 2026-01-26
Anderson Woodrow D
Chief Accounting Officer
2026-03-03
Heidbreder Christian
Chief Scientific Officer
2026-03-03
Preblick Ryan
Chief Financial Officer
2026-03-14
Humphreys Keith 2026-01-26